Search company, investor...
Cerecor company logo


Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price


About Cerecor

Cerecor focuses on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human brain.

Headquarters Location

540 Gaither Rd Suite 400

Rockville, Maryland, 20850,

United States


Missing: Cerecor's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cerecor's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Cerecor

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cerecor is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

1,568 items

Cerecor Patents

Cerecor has filed 11 patents.

The 3 most popular patent topics include:

  • Autosomal recessive disorders
  • NMDA receptor antagonists
  • Piperidines
patents chart

Application Date

Grant Date


Related Topics




NMDA receptor antagonists, Antidepressants, Piperidines, Fluoroarenes, Amines


Application Date


Grant Date



Related Topics

NMDA receptor antagonists, Antidepressants, Piperidines, Fluoroarenes, Amines



Latest Cerecor News

Alcohol Addiction Therapeutics Market Data and statistics | Evolving Opportunities With Bionex Pharmaceuticals LLC, Cerecor Inc and Chronos Therapeutics Ltd

Sep 26, 2022

| Evolving Opportunities With Bionex Pharmaceuticals LLC, Cerecor Inc and Chronos Therapeutics Ltd Pune, Maharashtra, India, September 26 2022 (Wiredrelease) Prudour Pvt. Ltd –: Global Alcohol Addiction Therapeutics Market : Introduction According to the National Institute on Alcohol Abuse and Alcoholism, about 18 million people in the United States suffer from alcohol use disorder. Of these, only 8 percent receive treatment. Alcohol addiction is a serious problem that can lead to death, but there are treatments available that can help people recover. The most effective treatment for alcohol addiction is a combination of counseling and medication. Counseling helps patients change their behavior and provides support during difficult times. Medication helps reduce withdrawal symptoms and cravings. Alcohol Addiction Therapeutics Market to See Substantial Growth in the Coming Years According to a new report by Research, the alcohol addiction therapeutics market is expected to grow substantially in the coming years. The report analyzes the market dynamics and provides insights into various factors that are expected to drive the growth of the market. Alcohol addiction is a serious problem that affects millions of people around the world. Despite the availability of various treatments, the prevalence of alcohol addiction remains high. The demand for effective therapeutics is therefore expected to rise in the coming years. This report provides valuable information to shareholders, new entrants, frontrunners, and shareholders. It helps them formulate strategies for the future, as well as take the necessary steps to strengthen their market position. The report includes graphical representations and tabular representations to provide an in-depth analysis of every segment as well as their sub-segments. This report is intended to aid market players, investors, new entrants, and others in formulating strategies based on the fastest-growing segments and highest revenue generation. data from the latest shows that North America in 2021 will be the largest Alcohol Addiction Therapeutics market. Mexico, Canada and the US are experiencing nominal CAGRs of [2022-2031] above the global average. Identify the key factors that will drive your company’s growth. Request a brochure of this report here:  [Sample reports can be used to check out our detailed reports and study material before purchasing]  1. The updated 150+ page reports give an in-depth analysis and commentary on the COVID-19 virus pandemic. 2. You can find out about industry data and interviews with experts to learn more about topics like regional impact analysis, global outlook, competitive landscape analysis, market size, share, and the size of regional markets. 3. These reports are available in PDF format. You can view them on your computer or print them. 4. PDF sample report provides additional information on Major Market Players including their Sales Volume, Business Strategy, Revenue Analysis and Revenue Analysis. This gives readers an advantage over other people. 5. The Research report includes a detailed analysis of key factors that influence the market’s growth. 6. Sample report also provides insight on major market players, their business strategies, and revenue analysis to give readers an edge over others. Alcohol Addiction Therapeutics Market – Competitive Landscape  AstraZeneca Plc Key Questions Answered in This Report:  Q1. What is the market size of Alcohol Addiction Therapeutics? Q2. What are the elements of retail Alcohol Addiction Therapeutics? Q3. What are the key decision drivers for service buyers? Q4. How can we accelerate our bidding process? Q5. What is the potential of the Alcohol Addiction Therapeutics Market? Q6. Who are the prominent players in Alcohol Addiction Therapeutics Market? Q7. What are the different types of Alcohol Addiction Therapeutics market? Q8. What are the top strategies that companies adopt in Alcohol Addiction Therapeutics Market? Q9. What is the future of Alcohol Addiction Therapeutics? Trending Reports (Book Now with Save 25% [Single User], 38% [Multi-User], 45% [Corporate Users] + Covid-19 scenario+ Impact of Russia-Ukraine war):

Cerecor Frequently Asked Questions (FAQ)

  • When was Cerecor founded?

    Cerecor was founded in 2011.

  • Where is Cerecor's headquarters?

    Cerecor's headquarters is located at 540 Gaither Rd, Rockville.

  • What is Cerecor's latest funding round?

    Cerecor's latest funding round is IPO.

  • How much did Cerecor raise?

    Cerecor raised a total of $45.19M.

  • Who are the investors of Cerecor?

    Investors of Cerecor include Apple Tree Partners, New Enterprise Associates, MPM Capital, The Column Group and Equity Source Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.